作者
Xin Ge,Ying Shen,Yu Han,Shenyu Li,Xiulong Feng,Chenxi Wang,Yuhui Xiong,Fan Zhao,Shasha Zhao,王晓东,Jing Zhang,Wen Wang
摘要
BACKGROUND: Quantitative MRI may enable noninvasive glioma characterization, but optimal analytic strategies and prognostic utility remain uncertain. PURPOSE: To compare volume-of-interest (VOI)-mean, radiomics, and 2D, 2.5D, and 3D deep learning (DL) for preoperative molecular classification and assess the prognostic value of a 2.5D-DL-derived isocitrate dehydrogenase wild-type score (2.5D-IDHwt score) in a postoperative clinicopathologic survival model. STUDY TYPE: Retrospective multicenter study. POPULATION: One thousand four hundred and eight adults with diffuse glioma: training (n = 409), temporal validation (n = 300), and three external test cohorts (n = 119, 310, and 270). FIELD STRENGTH/SEQUENCE: 3 T; spin-echo echo-planar diffusion-weighted imaging, 3D pseudo-continuous arterial spin labeling, and multidynamic multiecho synthetic MRI. ASSESSMENT: -methylguanine-DNA methyltransferase promoter methylation, and extent of resection and was compared with PathoClin incorporating pathological IDH status. STATISTICAL TESTS: Area under the curve (AUC), DeLong tests, Harrell C-index, bootstrap resampling, calibration, decision-curve analysis, Kaplan-Meier analysis, and Cox regression. p < 0.05 indicated significance. RESULTS: The 2.5D-DL stacking model achieved the highest external AUCs for IDH mutation (0.89-0.93) and 1p/19q codeletion (0.92-0.95), significantly outperforming the other four stacking models. Reverse Kaplan-Meier median follow-up was 1344 days (95% CI, 1316-1383); 27.5% died. External C-indices for 2.5D-qMR-Clin were 0.750, 0.778, and 0.762 versus 0.704, 0.722, and 0.723 for PathoClin, with significant differences in test cohorts 2 and 3. Fixed-cutoff risk stratification was significant across all external cohorts (hazard ratios, 5.30-5.80). A web-based 2.5D-qMR-Clin explorer provided 1-, 2-, and 3-year OS estimates. DATA CONCLUSION: Among evaluated approaches, 2.5D-DL stacking performed best for molecular classification, and the 2.5D-IDHwt score improved OS assessment in the postoperative clinicopathologic model. EVIDENCE LEVEL: 3. TECHNICAL EFFICACY: Stage 2.